Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1951 of 5804
-
New device tackles tough leg artery blockages in japanese patients
Disease control CompletedThis is a prospective, single-arm, multi-center study designed to evaluate the safety and efficacy of the Orbital Atherectomy System (OAS) for the treatment of adult Japanese subjects with a de novo symptomatic calcified occlusive atherosclerotic lesion in the superficial femoral…
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New scan could spot hidden amyloid in heart and organs
Diagnosis Recruiting nowThis is a single center prospective study evaluating 124I-evuzumitide in patients with systemic amyloidosis. The purpose of this study is to 1) Establish the diagnostic accuracy of 124I-evuzumitide in cardiac amyloidosis 2) Evaluate extracardiac uptake 3) identify and characteriz…
Phase: PHASE2 • Sponsor: Oregon Health and Science University • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
New drug shows promise for rare liver disease itch
Symptom relief CompletedThe main aim of the study is to check if TAK-625 improves symptoms of Progressive Familial Intrahepatic Cholestasis (PFIC), side effect from the study treatment or TAK-625, and how much TAK-625 stays in their blood over time. This will help the study sponsor (Takeda) to work out …
Phase: PHASE3 • Sponsor: Takeda • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Digital program aims to slash heart disease risk by lowering cholesterol
Disease control CompletedElevation in low density lipoprotein (LDL) cholesterol (LDL-C) is a causal risk factor for atherosclerotic established cardiovascular disease (ASCVD). Reduction of LDL-C with statins has been clearly demonstrated as a robust and cost-effective way of reducing the burden of ASCVD …
Phase: NA • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Personalized lung decline forecast aims to boost smoking cessation in COPD
Disease control CompletedThis study assesses the effect of a personalized smoking cessation infographic on physician smoking cessation counseling rates and smoking cessation pharmacotherapy prescription rates. The study assesses the difference in physician behaviour using an interrupted time series analy…
Sponsor: Unity Health Toronto • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
CBD drug shows promise for stubborn heart pain
Symptom relief CompletedPatients with recurrent pericarditis who are refractory or intolerant to current therapeutic management options or who require long-term administration of corticosteroids to control their disease are particularly challenging to manage. The pathogenesis of pericarditis involves th…
Phase: PHASE2 • Sponsor: Cardiol Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
HIV hiding spots revealed in treatment pause study
Knowledge-focused Recruiting nowBackground: Human immunodeficiency virus (HIV) infects CD4 T cells. There is no cure for HIV. People with HIV need to take daily medications called antiretroviral therapy (ART) to control their infection. ART stops HIV from infecting cells, but HIV does not go away. Some infecte…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New antibody PRL3-Zumab tested against advanced cancers
Disease control Recruiting nowThis is a Multi-Center, Phase II/III, open-label, single dose level (6 mg/kg) basket trial of PRL3-zumab monotherapy in solid cancer patients. The study will consist of a Screening Period (Day - 14 to Day -1) for completion of all screening assessments before the first administr…
Phase: PHASE2, PHASE3 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Gut bacteria may lift mood in bipolar depression
Symptom relief CompletedBipolar Disorder (BD) is highly incapacitating and associated with premature mortality. Depressive symptoms and episodes are the most frequent cause of disability in subjects with BD and over half of patients do not respond adequately to approved treatments for this condition, sh…
Phase: NA • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New program aims to cut PTSD and ER visits for trauma patients
Symptom relief OngoingThis investigation is a randomized pragmatic trial of a brief stepped care intervention delivered from an acute care medical trauma center that may both reduce the symptoms of posttraumatic stress disorder (PTSD) and diminish emergency department health service utilization.
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New eczema drug cibinqo under Real-World safety review in korea
Disease control Recruiting nowThe purpose of this non-interventional study is to learn about the safety and effectivness of Cibinqo Tablet for the possible treatment of atopic dermatitis (AD). AD is a long-lasting itchy red rash, caused by a skin reaction. This study is seeking participants who: 1. Are pat…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New gout pill aims to stop flare pain in 3 days
Symptom relief Recruiting nowThe purpose of this trial is to investigate the efficacy and safety of dapansutrile (OLT1177®) tablets in subjects with an acute gout flare.
Phase: PHASE2, PHASE3 • Sponsor: Olatec Therapeutics LLC • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Could a common diabetes drug ease Parkinson's symptoms?
Disease control CompletedParkinson's disease (PD) is one of the most common neurodegenerative diseases characterized by the progressive loss of dopaminergic (DA) neurons in the substantia nigra compacta (SNc) and aggregation of Lewy bodies in neurons. Although aging, oxidative damage and neuroinflammatio…
Phase: PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for advanced tumors: BL-M07D1 enters human testing
Disease control Recruiting nowEvaluation of BL-M07D1 for injection in Phase I clinical study of safety, tolerability, pharmacokinetic Characteristics, and initial efficacy in patients with locally advanced or metastatic digestive tract tumors and other solid tumors.
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Robot trainer aims to keep seniors on their feet during hospital stays
Disease control OngoingThis study aims to address if robot assisted physical training can prevent functional decline during acute hospitalisation in older geriatric patients. Design: blinded RCT. Patients: n = 488. Primary outcome is functional decline, assessed by Barthel-Index and 30s chair stand te…
Phase: NA • Sponsor: Odense University Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:52 UTC
-
Memory tricks may boost PTSD therapy success
Symptom relief Recruiting nowThe efficacy of psychological interventions for posttraumatic stress disorder (PTSD) is likely limited by the difficulty participants have learning and remembering important therapy content. Accordingly, the present study will examine the utility of integrating a Memory Support (…
Phase: NA • Sponsor: Boston University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Can a breathing gadget curb addiction cravings?
Disease control CompletedHeart rate variability biofeedback (HRVB) is an biobehavioral intervention involving rhythmic breathing at resonance frequency that stimulates cardiovascular regulatory systems to help individuals better regulate affect and bolster cognitive control. This intervention has already…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a simple toolkit make telemedicine work for burn emergencies?
Knowledge-focused Recruiting nowThe study team will use implementation science to accelerate the uptake of teleconsultationfor burn patients by 1) examining the relationships between clinician perceptions of acceptability, feasibility, intention to use, and actual use of burn teleconsultation 2) identifying the…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
New diabetes combo pill shows promise in Late-Stage trial
Disease control CompletedA multicenter, randomized, double-blind, placebo-controlled, parallel, phase Ⅲ study to evaluate the efficacy and safety of JW0201 added on in patients with type 2 diabetes mellitus who have inadequate glycemic control with C2202 and C2203
Phase: PHASE3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated Jun 26, 2026 14:35 UTC
-
New drug trial offers hope for Hard-to-Treat cancers
Disease control TerminatedThis study will test the safety of a drug called PF-08046049/SGN-BB228 in participants with melanoma and other solid tumors that are hard to treat or have spread through the body. It will also study the side effects of this drug. A side effect is anything a drug does to the body …
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC